Soon we’ll not be supporting this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Interpace Biosciences Inc (IDXG) NPV

Sell:$8.90 Buy:$8.90 Change: No change
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Change: No change
Deal now Deal for just £11.95 per trade in a Fund and Share Account
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
Change: No change
Market closed |  Prices as at close on 17 September 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Interpace Biosciences, Inc. is an independent molecular diagnostics and biopharma services company. The Company is focused on providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. It offers services along with the therapeutic value chain from early diagnosis and prognostic planning to target therapeutic applications through its clinical and pharma services. Its clinical services provide clinically useful molecular diagnostic tests, bioinformatics and pathology services for evaluating risk of cancer by leveraging the latest technology in personalized medicine for improved patient diagnosis and management. Its pharma services provide pharmacogenomics testing, genotyping, biorepository and other services to the pharmaceutical and biotech industries. The Company's products include ThyGenNEXT, ThyraMIR, PancraGEN, RespriDX and BarreGen.

Contact details

Morris Corporate Center 1
, Building C, 300 Interpace Parkway
United States
+1 (412) 2246100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$36.83 million
Shares in issue:
4.16 million
Health Care Services
Off Exchange
United States
US dollar

Key personnel

  • Thomas Burnell
    President, Chief Executive Officer, Director
  • Thomas Freeburg
    Chief Financial Officer, Treasurer, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.